Work

Use, Spending, and Prices of Adalimumab Following Biosimilar Competition

Year: 2024

Type: article

Abstract: This cross-sectional study examines the use, spending, and prices of adalimumab biosimilars in the first year of market competition in the US.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2024.3964

Authors: Benjamin N. Rome, Anushka Bhaskar, Aaron S. Kesselheim

Institutions: Brigham and Women's Hospital, Harvard University

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000

Funder: Arnold Ventures

OpenAlex ID: W4405365584

FWCI: 1.667

Cites: 4

Cited by: 12

Related to: 10